BU-32: A novel proteasome inhibitor for breast cancer

Joseph K Agyin, Bindu Santhamma, Hareesh B. Nair, Sudipa S. Roy, Rajeshwar R. Tekmal

Resultado de la investigación: Articlerevisión exhaustiva

15 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'BU-32: A novel proteasome inhibitor for breast cancer'. En conjunto forman una huella única.

Medicine and Dentistry

Chemistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology